FDA approves new psoriasis drug || Valeant Pharmaceuticals || Katalyst HLS


The U.S. Food and Drug Administration today approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection.
http://www.fda.gov/ || http://www.KatalystHLS.com
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm541981.htm

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s